Drugs Approved for Colon Cancer
- Adagrasib
- Alymsys (Bevacizumab)
- Avastin (Bevacizumab)
- Bevacizumab
- Camptosar (Irinotecan Hydrochloride)
- Capecitabine
- Cetuximab
- Cyramza (Ramucirumab)
- Eloxatin (Oxaliplatin)
- Erbitux (Cetuximab)
- 5-FU (Fluorouracil Injection)
- Fluorouracil Injection
- Fruquintinib
- Fruzaqla (Fruquintinib)
- Ipilimumab
- Irinotecan Hydrochloride
- Keytruda (Pembrolizumab)
- Krazati (Adagrasib)
- Leucovorin Calcium
- Lonsurf (Trifluridine and Tipiracil Hydrochloride)
- Lumakras (Sotorasib)
- Mvasi (Bevacizumab)
- Nivolumab
- Nivolumab and Hyaluronidase-nvhy
- Opdivo (Nivolumab)
- Opdivo Qvantig (Nivolumab and Hyaluronidase-nvhy)
- Oxaliplatin
- Panitumumab
- Pembrolizumab
- Ramucirumab
- Regorafenib
- Sotorasib
- Stivarga (Regorafenib)
- Trifluridine and Tipiracil Hydrochloride
- Tucatinib
- Tukysa (Tucatinib)
- Vectibix (Panitumumab)
- Xeloda (Capecitabine)
- Yervoy (Ipilimumab)
- Zaltrap (Ziv-Aflibercept)
- Zirabev (Bevacizumab)
- Ziv-Aflibercept
Drug Combinations Used in Colon Cancer
Drugs Approved for Rectal Cancer
- Adagrasib
- Alymsys (Bevacizumab)
- Avastin (Bevacizumab)
- Bevacizumab
- Camptosar (Irinotecan Hydrochloride)
- Capecitabine
- Cetuximab
- Cyramza (Ramucirumab)
- Eloxatin (Oxaliplatin)
- Erbitux (Cetuximab)
- 5-FU (Fluorouracil Injection)
- Fluorouracil Injection
- Fruquintinib
- Fruzaqla (Fruquintinib)
- Ipilimumab
- Irinotecan Hydrochloride
- Keytruda (Pembrolizumab)
- Krazati (Adagrasib)
- Leucovorin Calcium
- Lonsurf (Trifluridine and Tipiracil Hydrochloride)
- Lumakras (Sotorasib)
- Mvasi (Bevacizumab)
- Nivolumab
- Nivolumab and Hyaluronidase-nvhy
- Opdivo (Nivolumab)
- Opdivo Qvantig (Nivolumab and Hyaluronidase-nvhy)
- Oxaliplatin
- Panitumumab
- Pembrolizumab
- Ramucirumab
- Regorafenib
- Sotorasib
- Stivarga (Regorafenib)
- Trifluridine and Tipiracil Hydrochloride
- Tucatinib
- Tukysa (Tucatinib)
- Vectibix (Panitumumab)
- Xeloda (Capecitabine)
- Yervoy (Ipilimumab)
- Zaltrap (Ziv-Aflibercept)
- Zirabev (Bevacizumab)
- Ziv-Aflibercept
Drug Combinations Used in Rectal Cancer
Drugs Approved for Gastroenteropancreatic Neuroendocrine Tumors